Keeping it real: Anticounterfeiting strategies in the pharmaceutical industry

Managerial and Decision Economics

Volumn 29, Issue 5, 2008, Pages 389-405

  Lybecker, Kristina M ^a,b  

^a University of Colorado College of Nursing   (United States)

^b LAKE FOREST COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48349123279     PISSN: 01436570     EISSN: 10991468     Source Type: Journal    
DOI: 10.1002/mde.1405     Document Type: Article

References (50)

1. Abbott Laboratories. 2004. Exclusive Sourcing Policy. World Wide Web Posting, April 2004. Available at: www.abbott.com
2. Abboud L, Mathews AW, Tesoriero HW. Fakes in the medicine chest: As drug counterfeiting rises, FDA may propose changes in sales, distribution network, The Wall Street Journal (Eastern edn); 22 September 2003; B1
3. AIPM (Association of International Pharmaceutical Manufacturers). 2001. Counterfeit drugs in Russia. AIPM Position Paper.
4. Angwin J, Bialik C. 2004. Web druggist with a cause; KwikMed, an online seller of Viagra, Cialis, Propecia, thinks it merits some respect. The Wall Street Journal (Eastern Edition) vol. 16, November 2004; B1.
5. Bale H. 2003. WHO should build partnerships with the pharmaceutical industry to improve public health. The Lancet 361(9351): 4.
6. Chatterjee P. 2001. India's trade in fake drugs - bringing the counterfeiters to book. The Lancet 357: 1776.
7. Christian J. 2001. Continuing Concerns over Imported Pharmaceuticals. Prepared Witness Testimony, the Committee on Energy and Commerce, US House of Representatives, Subcommittee on Oversight and Investigations.
8. Cohen JC, Lybecker KM. 2005. AIDS policy and pharmaceutical patents: Brazil's strategy to safeguard public health. The World Economy, Spring 2005; 211-230.
9. Crouch G. 2003. Europeans investigate resale of AIDS drugs. The New York Times, World Wide Web Posting, 29 October 2003. Available at: www.nytimes.com
10. Datta PTJ. 2003. India turning capital for counterfeit drugs. Financial Times, World Wide Web Posting, 3 August 2003. Available at www.ft.com
11. Dingell JD. 2003. Excerpt from the Congressional Record of Congressman John D. Dingell's statement before the House of Representatives. H7597-H7598, World Wide Web Posting, 24 July 2003. Available at www.house.gov
12. Ganslandt M, Maskus KE. 2001. Parallel imports of pharmaceutical products in the European Union. Policy Research Working Paper No. 2630, The World Bank, Development Research Group, Trade, Washington, DC.
13. Gibson L. 2004. Drug regulators study global treaty to tackle counterfeit drugs. British Medical Journal 328(7438): 486.
14. Goodman PS. 2002. China's big headache: fake pharmaceuticals. The Washington Post, 30 August 2002; Al.
15. GPHF [German Pharma Health Fund]. 2001. Counter-feit Medicines-An Unscrupulous Business. World Wide Web Posting, Fall 2001. Available at www.gphf.org
16. Grady D. 2003. F.D.A. Outlines plans to counter growing trade in fake pharmaceuticals. The New York Times, World Wide Web Posting, 3 October 2003. Available at www.nytimes.com
17. ten Ham M. 1992. Counterfeit drugs: implications for health. Adverse Drug Reaction Toxicological Review. 11(1): 59-65.
18. ten Ham M. 2002. Impact on patients. In Protecting Medicines and Pharmaceuticals: A Manual of Anticounterfeiting Solutions, LePark M (ed.). Reconnaissance International: Greenwood Village, CO; 21-24.
19. Harbaugh R, Khemka R. 2000. Does copyright enforcement encourage piracy? Claremont Economics Working Paper 2000-14, Claremont McKenna College.
20. Hensley S. 2003. New J&J policy aims to thwart counterfeits. The Wall Street Journal (Eastern edn), 11 December 2003; M1.
21. Hopkins DM, Kontnik LT, Turnage MT. 2003. Counterfeiting Exposed: Protecting Your Brand and Customers. Wiley: Hoboken, NJ.
22. Kontnik LT. 1998. Firms have an obligation and an opportunity to protect their drugs. Pharmaceutical and Medical Packaging News, March 1998.
23. Knox R. 2003. Counterfeit drugs. NPR News Broadcast Transcript, 29 July 2003 Available at http://discover.npr.org
24. Lee HL, Padmanabhan V, Whang S. 1997. Information distortion in a supply chain: the bullwhip effect. Management Science 43(4): 546-558.
25. Lenox M. 2001. Overcoming agency and information problems in the diffusion of best practice within firms. Working Paper.
26. LePark M. 2002. Impact on the company. In Protecting Medicines and Pharmaceuticals: A Manual of Anticounterfeiting Solutions (Chapter 5), LePark M (ed.) Reconnaissance International: Greenwood Village, CO; 25-32.
27. Lybecker KM. 2000. Product piracy: the sale of counterfeit pharmaceuticals in developing countries. Doctoral Dissertation, Department of Economics, University of California, Berkeley, CA.
28. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Chotivanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ. 2001. Fake artesunate in southeast Asia. The Lancet 357: 1948-1950.
29. Newton PN, White NJ, Rozendaal JA, Green MD. 2002. Murder by fake drugs. British Medical Journal 324: 800-801.
30. O'Connor A. 2003. How consumers should check drugs. The New York Times, World Wide Web Posting, 3 October 2003. Available at www.nytimes.com
31. Pfizer. 2004. Pfizer Plans to Incorporate RFID Technology into Viagra Packaging in US. World Wide Web Posting, 15 November 2004. Available at www.pfizer.com
32. PhRMA [Pharmaceutical Research and Manufacturers of America]. 2004. Q&A: Tough Questions, Straight Answers. World Wide Web Posting, Available at www.phrma.org
33. Rassool GH. 2004. Substandard and counterfeit medicines. Journal of Advanced Nursing 46(3): 338-339.
34. Saywell T, McManus J. 2002. What's in that pill? Far Eastern Economic Review 165(7): 34-37.
35. Schwab D. 2003. Drug firms, FDA come to grips with counterfeits. Star-Ledger. World Wide Web Posting, 28 September 2003. Available at www.nj.com
36. Scrip. 2003. The scale of counterfeiting in Russia. Scrip, 31 March 2003.
37. Tavis LA, Williams OF (eds). 1993. The Pharmaceutical Corporate Presence in Developing Countries. University of Notre Dame Press: Notre Dame, IN.
38. Tesoriero HW. 2005a. Fake-drug sales thrive on web. The Wall Street Journal (Eastern edn); 28 April 2005(a); D4.
39. Tesonero HW. 2005b. Cardinal health ends drug trading; move is regarded by some as step to leave business blamed for fake products. The Wall Street Journal (Eastern edn); 6 May 2005(b); B2.
40. Tesoriero HW. 2005c. CVS will try to close one gap where counterfeit drugs enter. The Wall Street Journal (Eastern edn); 25 May 2005(c); D4.
41. Tesonero HW. 2005d. Purdue Pharma, H.D. Smith plan test of electronic tracking of drugs. The Wall Street Journal (Eastern edn); 31 May 2005(d); D7.
42. Thompson CA. 2003. Counterfeit drugs arise from various sources. American Journal of Health-System Pharmacy 60(15): 1506.
43. United States Food and Drug Administration (USFDA). 2005. Combating Counterfeit Drugs: A Report of the Food and Drug Administration. Annual Update, World Wide Web Posting, 18 May 2005. Available at http://www.fda.gov/oc/ initiatives/counterfeit/update2005.html
44. Vollmer S. 2003. Poison Pills: How N.C. wants to avoid counterfeit drugs flooding market. Triangle Business Journal. 31 January 2003 (online edn). Available at http://triangle.bizjournals.com/triangle/stories/2003/02/ 03/story2.html
45. World Health Organization. 1992. Counterfeit Drugs: Report of a WHO/IFPMA Workshop, WHO/DMP/CFD/92, World Health Organization: Geneva.
46. World Health Organization, Division of Drug Management & Policies and Action Programme on Essential Drugs. 1997. Counterfeit Drugs: Report of the International Workshop on Counterfeit Drugs. WHO/DRS/CFD/98.1, World Health Organization: Geneva.
47. World Health Organization. 1999. Counterfeit drugs - guidelines for the development of measures to combat counterfeit drugs. Ref. No. WHO/EDM/QSM/99.1, World Health Organization: Geneva, Switzerland, Available at www.who.int
48. World Health Organization. 2000. Counterfeit drugs: cottage industry or organized crime? Press Release WHA/012, World Health Organization: Geneva.
49. World Health Organization. 2002. Counterfeit drugs: an overview. In Protecting Medicines and Pharmaceuticals: A Manual of Anticounterfeiting Solutions, LePark M (ed.). Reconnaissance International: Greenwood Village, CO; 9-16.
50. yjgjg Project. 1996. World Wide Web Posting: counterfeit drugs. 5 December 1996. Available at http://tron.um.u-tokoyo.ac.jp/WHO/programmes/dap/ countfe1.html